  {"id":7316,"date":"2018-11-19T08:16:02","date_gmt":"2018-11-19T13:16:02","guid":{"rendered":"https:\/\/www.vanderbilt.edu\/vise\/?p=7316"},"modified":"2018-11-19T08:18:18","modified_gmt":"2018-11-19T13:18:18","slug":"fall-seminar-chris-west","status":"publish","type":"post","link":"https:\/\/www.vanderbilt.edu\/vise\/fall-seminar-chris-west\/","title":{"rendered":"Fall Seminar &#8211; Chris West"},"content":{"rendered":"<p>to be led by<\/p>\n<h4>Chris West<br \/>\nPresident,<br \/>\nZeroTo510 Medical Device Accelerator<\/h4>\n<p><img loading=\"lazy\" class=\"wp-image-7317 alignnone\" src=\"https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2018\/11\/19170805\/Chris-West-2-240x300.jpg\" alt=\"\" width=\"204\" height=\"255\" srcset=\"https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2018\/11\/19170805\/Chris-West-2-240x300.jpg 240w, https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2018\/11\/19170805\/Chris-West-2-768x960.jpg 768w, https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2018\/11\/19170805\/Chris-West-2-520x650.jpg 520w, https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2018\/11\/19170805\/Chris-West-2-80x100.jpg 80w, https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2018\/11\/19170805\/Chris-West-2.jpg 1280w\" sizes=\"(max-width: 204px) 100vw, 204px\" \/><\/p>\n<p><strong>Title:<\/strong><br \/>\n\u201cWhat we\u2019ve learned in device innovation (the hard way): Practical tips in translation\u201d<\/p>\n<p><strong>Abstract:<\/strong><br \/>\nZeroTo510 is a Memphis-based medical device Accelerator, and is annually ranked among the top programs in the country. We\u2019ve taken 30 startup teams through our program in 7 cohorts, and 6 teams have achieved FDA Clearance with their lead product and another 2 are currently under FDA review. Innova Memphis, our investment partner, is one of the country\u2019s most prolific early stage investors and has invested in over 50 medical device companies, so we have deep experience with startup device teams in our ecosystem.<\/p>\n<p>Each year we formally assess 50-75 applications, and generally accept 2-5 teams into our summer program. We also know that most of our teams will never gain FDA Clearance for their lead product. In this talk I will share the method we use to assess early-stage technologies and teams, as well as lessons we\u2019ve learned (the hard way) about what separates success from failure in this business. Spoiler alert: it\u2019s usually not the product!<\/p>\n<p><strong>Bio:<\/strong><br \/>\nI\u2019m a former executive in the Pharmaceutical\/Biotech industry. I started my career as a Sales Representative in the Raleigh-Durham area, and was hired to launch a new drug. That seems to characterize my career: I\u2019ve been part of countless product launches, both in sales leadership roles (up to VP of Sales), marketing leadership roles (I\u2019ve worked on some of the biggest Brands in the industry), and in roles where I led both functions. I\u2019ve also been fortunate enough to work with talented researchers and clinicians in prioritizing efforts behind early stage projects, the lifeblood of large Pharma organizations. I moved to Memphis to set up the commercialization organization for a startup Biotech company, and when their products failed in Phase III trials I found myself at ZeroTo510, working with medical device inventors. I am drawn to the vision and energy of inventors, and take great pride in helping them bring their ideas to life.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>to be led by Chris West President, ZeroTo510 Medical Device Accelerator Title: \u201cWhat we\u2019ve learned in device innovation (the hard way): Practical tips in translation\u201d Abstract: ZeroTo510 is a Memphis-based medical device Accelerator, and is annually ranked among the top programs in the country. We\u2019ve taken 30 startup teams through our program in 7 cohorts,&#8230;<\/p>\n","protected":false},"author":670,"featured_media":7317,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false,"jetpack_publicize_feature_enabled":true,"_links_to":"","_links_to_target":""},"categories":[12],"tags":[411,32,92,413,72,31,30,412],"acf":[],"jetpack_featured_media_url":"https:\/\/cdn.vanderbilt.edu\/vu-URL\/wp-content\/uploads\/sites\/193\/2018\/11\/19170805\/Chris-West-2.jpg","jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p98pzF-1U0","_links":{"self":[{"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/posts\/7316"}],"collection":[{"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/users\/670"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/comments?post=7316"}],"version-history":[{"count":1,"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/posts\/7316\/revisions"}],"predecessor-version":[{"id":7318,"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/posts\/7316\/revisions\/7318"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/media\/7317"}],"wp:attachment":[{"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/media?parent=7316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/categories?post=7316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vanderbilt.edu\/vise\/wp-json\/wp\/v2\/tags?post=7316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}